Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,925
Total Claims
$2.9M
Drug Cost
781
Beneficiaries
$3,677
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+213%
Cost per patient vs peers
$3,677 vs $1,174 avg
+161%
Brand preference vs peers
23.2% vs 8.9% avg
Brand vs Generic
Brand: 4,323 claims · $2.4M
Generic: 14,337 claims · $505K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 906 | $393K |
| Diclofenac Epolamine | 318 | $217K |
| Empagliflozin | 219 | $166K |
| Fluticasone/Umeclidin/Vilanter | 218 | $165K |
| Tenofovir Alafenamide | 91 | $135K |
| Dapagliflozin Propanediol | 161 | $110K |
| Linaclotide | 170 | $97K |
| Sitagliptin Phosphate | 113 | $93K |
| Sitagliptin Phos/Metformin Hcl | 89 | $60K |
| Denosumab | 32 | $55K |
| Clemastine Fumarate | 20 | $51K |
| Lactulose | 23 | $48K |
| Budesonide/Glycopyr/Formoterol | 68 | $48K |
| Lipase/Protease/Amylase | 50 | $44K |
| Rivaroxaban | 66 | $44K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data